Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:1331

Myopia Global Clinical Trials Review, Q2, 2011

Myopia Global Clinical Trials Review, Q2, 2011

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $1,000.00
Meta Description Myopia Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, “Myopia Global Clinical Trials
Publisher GlobalData
Date of Report Jun 15, 2011
Quick Overview
Myopia Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, “Myopia Global Clinical Trials Review, Q2, 2011" provides data on the Myopia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myopia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myopia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Myopia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Unaccomplished Trials of Myopia 19
Subjects Recruited Over a Period of Time 21
Prominent Sponsors 22
Top Companies Participating in Myopia Therapeutics Clinical Trials 24
Prominent Drug Comparison 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Bp Consulting Inc 27
Clinical Trial Overview of Bp Consulting Inc 27
CoDa Therapeutics, Inc. 28
Clinical Trial Overview of CoDa Therapeutics, Inc. 28
OXiGENE, Inc. 29
Clinical Trial Overview of OXiGENE, Inc. 29
Bayer AG 30
Clinical Trial Overview of Bayer AG 30
Novartis AG 31
Clinical Trial Overview of Novartis AG 31
Technolas Perfect Vision GmbH 32
Clinical Trial Overview of Technolas Perfect Vision GmbH 32
Clinical Trial Overview of Top Universities / Institutes / Hospitals 33
Walter Reed Army Medical Center 33
Clinical Trial Overview of Walter Reed Army Medical Center 33
Stanford University 34
Clinical Trial Overview of Stanford University 34
Singapore National Eye Centre 35
Clinical Trial Overview of Singapore National Eye Centre 35
The University of Utah 36
Clinical Trial Overview of The University of Utah 36
Yonsei University 37
Clinical Trial Overview of Yonsei University 37
Far Eastern Memorial Hospital 38
Clinical Trial Overview of Far Eastern Memorial Hospital 38
The Hong Kong Polytechnic University 39
Clinical Trial Overview of The Hong Kong Polytechnic University 39
Shaheed Beheshti Medical University 40
Clinical Trial Overview of Shaheed Beheshti Medical University 40
University of Waterloo 41
Clinical Trial Overview of University of Waterloo 41
Massachusetts Eye and Ear Infirmary 42
Clinical Trial Overview of Massachusetts Eye and Ear Infirmary 42
Chang Gung Memorial Hospital 43
Clinical Trial Overview of Chang Gung Memorial Hospital 43
Medical University of South Carolina 44
Clinical Trial Overview of Medical University of South Carolina 44
Samsung Medical Center 45
Clinical Trial Overview of Samsung Medical Center 45
Sun Yat-sen University 46
Clinical Trial Overview of Sun Yat-sen University 46
University Hospital Freiburg 47
Clinical Trial Overview of University Hospital Freiburg 47
Kyoto University 48
Clinical Trial Overview of Kyoto University 48
University of Michigan 49
Clinical Trial Overview of University of Michigan 49
The Ohio State University 50
Clinical Trial Overview of The Ohio State University 50
University Hospital Inselspital, Berne 51
Clinical Trial Overview of University Hospital Inselspital, Berne 51
Federal University of Sao Paulo 52
Clinical Trial Overview of Federal University of Sao Paulo 52
Appendix 53
Abbreviations 53
Definitions 53
Research Methodology 54
Secondary Research 54
About GlobalData 55
Contact Us 55
Disclaimer 55
Source 56




...